The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 25, 2021

Filed:

Jun. 13, 2016
Applicant:

Nexus Dx, Inc., San Diego, CA (US);

Inventors:

Michelle Davey, Brampton, CA;

George Jackowski, Kettleby, CA;

Peter Kupchak, Toronto, CA;

Eric Stanton, Burlington, CA;

Assignee:

NEXUS DX, INC., San Diego, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/74 (2006.01); C07K 16/26 (2006.01); G01N 33/535 (2006.01); C12N 5/16 (2006.01); G01N 33/543 (2006.01); G01N 33/68 (2006.01); G01N 33/545 (2006.01);
U.S. Cl.
CPC ...
G01N 33/74 (2013.01); C07K 16/26 (2013.01); C12N 5/163 (2013.01); G01N 33/535 (2013.01); G01N 33/543 (2013.01); G01N 33/6893 (2013.01); C07K 2317/31 (2013.01); C07K 2317/34 (2013.01); G01N 33/545 (2013.01); G01N 2333/58 (2013.01); G01N 2800/325 (2013.01); G01N 2800/56 (2013.01); G01N 2800/7019 (2013.01); Y10S 436/811 (2013.01); Y10S 530/80 (2013.01);
Abstract

A specific and sensitive in vitro ELISA assay and diagnostic test kit is disclosed for determining levels of NT-proBNP protein in a variety of bodily fluids, non-limiting examples of which are blood, serum, plasma, urine and the like. The NT-proBNP ELISA assay test employs the sandwich ELISA technique to measure circulating NT-proBNP in human plasma. In order to obtain antibodies with specific binding properties for targeted amino acid sequences within human proBNP, recombinant human proBNP (or rhproBNP) was expressed and purified for use as an immunogen. Polyclonal antibodies (PAb) to specific amino acid sequences were subsequently purified from goat serum by sequential affinity purification. Monoclonal antibodies were raised against specific polypeptides. Recombinant human NT-proBNP (or rhNT-proBNP) was expressed and purified in order to obtain material for use in calibration of a quantitative method for measurement of human NT-proBNP.


Find Patent Forward Citations

Loading…